Pharmacist-led medication review in community settings: An overview of systematic reviews
- PMID: 27665364
- DOI: 10.1016/j.sapharm.2016.08.005
Pharmacist-led medication review in community settings: An overview of systematic reviews
Abstract
Background: Pharmacist-led medication review is a collaborative service which aims to identify and resolve medication-related problems.
Objective: To critically evaluate published systematic reviews relevant to pharmacist-led medication reviews in community settings.
Methods: MEDLINE, EMBASE, International Pharmaceutical Abstracts (IPA), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane Database of Systematic Reviews (CDSR) were searched from 1995 to December 2015. Systematic reviews of all study designs and outcomes were considered. Methodological quality was assessed using the 11-item Assessment of Multiple Systematic Reviews (AMSTAR) tool. Systematic reviews of moderate or high quality (AMSTAR ≥ 4) were included in the data synthesis. Data extraction and quality assessment was performed independently by two investigators.
Results: Of the 35 relevant systematic reviews identified, 24 were of moderate and seven of high quality and were included in the data synthesis. The largest overall numbers of unique primary research studies with favorable outcomes were for diabetes control (78% of studies reporting the outcome), blood pressure control (74%), cholesterol (63%), medication adherence (56%) and medication management (47%). Significant reductions in medication and/or healthcare costs were reported in 35% of primary research studies. Meta-analysis was performed in 12 systematic reviews. Results from the meta-analyses suggested positive impacts on glycosylated hemoglobin, blood pressure, cholesterol, and number and appropriateness of medications. Conflicting findings were reported in relation to hospitalization. No meta-analyses reported reduced mortality.
Conclusion: Moderate and high quality systematic reviews support the value of pharmacist-led medication review for a range of clinical outcomes. Further research including more rigorous cost analyses are required to determine the impact of pharmacist-led medication reviews on humanistic and economic outcomes. Future systematic reviews should consider the inclusion of both qualitative and quantitative studies to comprehensively evaluate medication review.
Keywords: Community pharmacy services; Drug-related side effects and adverse reactions; Inappropriate prescribing; Medication therapy management; Pharmacists; Systematic review.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews.Prim Care Diabetes. 2020 Oct;14(5):393-400. doi: 10.1016/j.pcd.2019.12.007. Epub 2020 Jan 8. Prim Care Diabetes. 2020. PMID: 31926868
-
Impact of pharmacist-delivered interventions on pain-related outcomes: An umbrella review of systematic reviews and meta-analyses.Res Social Adm Pharm. 2024 Jun;20(6):34-51. doi: 10.1016/j.sapharm.2024.03.005. Epub 2024 Mar 13. Res Social Adm Pharm. 2024. PMID: 38514293
-
Community Pharmacists' Contribution to Medication Reviews for Older Adults: A Systematic Review.J Am Geriatr Soc. 2018 Aug;66(8):1613-1620. doi: 10.1111/jgs.15416. Epub 2018 Jul 4. J Am Geriatr Soc. 2018. PMID: 29972691
-
Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review.JBI Database System Rev Implement Rep. 2018 Sep;16(9):1823-1873. doi: 10.11124/JBISRIR-2017-003697. JBI Database System Rev Implement Rep. 2018. PMID: 30204671
-
Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review.Res Social Adm Pharm. 2020 Sep;16(9):1155-1165. doi: 10.1016/j.sapharm.2019.12.016. Epub 2020 Jan 14. Res Social Adm Pharm. 2020. PMID: 31959565
Cited by
-
The Ontario Pharmacy Evidence Network Atlas of MedsCheck services.Can Pharm J (Ott). 2022 Mar 9;155(3):151-156. doi: 10.1177/17151635221080457. eCollection 2022 May-Jun. Can Pharm J (Ott). 2022. PMID: 35519084 Free PMC article. No abstract available.
-
Community pharmacists' perspectives on implementation of Medicines Use Review in Slovenia.Int J Clin Pharm. 2018 Oct;40(5):1180-1188. doi: 10.1007/s11096-018-0644-6. Epub 2018 Jun 16. Int J Clin Pharm. 2018. PMID: 29909563
-
Clinical impact of a pharmacist-led medication review with follow up for aged polypharmacy patients: A cluster randomized controlled trial.Pharm Pract (Granada). 2020 Oct-Dec;18(4):2133. doi: 10.18549/PharmPract.2020.4.2133. Epub 2020 Oct 21. Pharm Pract (Granada). 2020. PMID: 33149794 Free PMC article.
-
Intervention description of pharmacist-facilitated medication reviews in Nordic primary care settings: a scoping review.Scand J Prim Health Care. 2025 Mar;43(1):241-253. doi: 10.1080/02813432.2024.2439909. Epub 2024 Dec 27. Scand J Prim Health Care. 2025. PMID: 39731253 Free PMC article.
-
Remunerated patient care services and injections by pharmacists: An international update.Can Pharm J (Ott). 2019 Jan 24;152(2):92-108. doi: 10.1177/1715163518811065. eCollection 2019 Mar-Apr. Can Pharm J (Ott). 2019. PMID: 30886662 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical